Author/

Treatment

Patient No.

Efficacy

Response (%)

PFS (%)

Survival (%)

CR

PR

SD

2 years

3 years

4 years

5 years

2 years

3 years

4 years

5 years

10 years

15 years

Packer, et al. 1997 [4] Carboplatin, Vincristine

78

5.1

28.2

60.2

75

68

-

-

-

-

-

-

-

-

Prados, et al. 1997 [5] Nitrosourea and multiagent chemotherapy

42

0

35.7

59.5

-

45

-

-

-

-

-

78

-

-

Gururangan, et al. 2002 [6]

Carboplatin

80

2

17

50

-

64

-

-

84

-

-

-

-

-

Burzynski, et al. 2016, Antineoplastons

16

25

12.5

37.5

61.9

55.0

48.1

48.1

81.3

74.5

67.7

67.7

54.2

54.2